Literature DB >> 8043286

Pneumonectomy for bronchogenic carcinoma in the elderly.

J Au1, R el-Oakley, E W Cameron.   

Abstract

We have reviewed 70 consecutive elderly patients (70 years or older) who underwent pneumonectomy for bronchogenic carcinoma, in order to evaluate morbidity, mortality, and long-term survival. The majority of the patients had stage II (n = 32) or III (n = 25) disease. Fifteen deaths occurred in the peri-operative period (21%). Pre-operative factors associated with peri-operative death included a history of ischaemic heart disease (P = 0.001) and right-sided tumour (peri-operative mortality for right pneumonectomy = 37%, left pneumonectomy = 6%, P = 0.001). Poor lung function (as assessed by pre-operative spirometry), peripheral vascular disease, cerebrovascular disease, diabetes mellitus, and hypertension were not significant risk factors for peri-operative death. Post-operatively, the requirement for ventilation, or the development of post-operative myocardial infarction, adult respiratory distress syndrome and respiratory failure were significantly associated with peri-operative death. Over 60% of the patients developed one or more complications. The absolute survival rates for operative survivors were 51% and 27% at 1 and 5 years, respectively (stage I, 60% and 40%; stage II, 63% and 33%; stage III 33% and 14%). The absolute overall survival rates were 40% and 21% at 1 and 5 years, respectively. We conclude that pneumonectomy is justified in elderly patients but right-sided lesions and ischaemic heart disease should be considered as relative contra-indications.

Entities:  

Mesh:

Year:  1994        PMID: 8043286     DOI: 10.1016/1010-7940(94)90154-6

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

1.  BTS guidelines: guidelines on the selection of patients with lung cancer for surgery.

Authors: 
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

Review 2.  Lung cancer 7: management of lung cancer in elderly patients.

Authors:  R Booton; M Jones; N Thatcher
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

Review 3.  Modifiable risk factors for patients undergoing lung cancer surgery and their optimization: a review.

Authors:  Sylvain Gagné; Daniel I McIsaac
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

4.  Spontaneous contralateral pneumothorax following pneumonectomy.

Authors:  J G Hubbard; U U Nkere; N K Bhatnagar
Journal:  Postgrad Med J       Date:  1997-02       Impact factor: 2.401

Review 5.  Diabetes and cancer I: risk, survival, and implications for screening.

Authors:  Adedayo A Onitilo; Jessica M Engel; Ingrid Glurich; Rachel V Stankowski; Gail M Williams; Suhail A Doi
Journal:  Cancer Causes Control       Date:  2012-05-03       Impact factor: 2.506

Review 6.  Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis.

Authors:  Bethany B Barone; Hsin-Chieh Yeh; Claire F Snyder; Kimberly S Peairs; Kelly B Stein; Rachel L Derr; Antonio C Wolff; Frederick L Brancati
Journal:  Diabetes Care       Date:  2010-04       Impact factor: 19.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.